Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.09.014Source: DataRank Database

Combination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer is a research paper published in Journal of Controlled Release (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.88)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Emily K. Bromley ORCID,Jae-Ho Shin ORCID,Tyvette S. Hilliard ORCID,Yueying Liu ORCID,Caitlin Horgan

Live enrichment

PubMed:39271060 PMC:PMC11486564 OpenAlex:https://openalex.org/W4402549051

National Cancer Institute

Grant: RO1CA109545

National Cancer Institute

Grant: UO1CA236979

NCI NIH HHS

Grant: R01 CA109545

NCI NIH HHS

Grant: U01 CA236979

University of Notre Dame Mike and Josie Harper Cancer Research Institute

National Institutes of Health

FWCI

0.88

Citation Percentile

0.7%

Citation Trend

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11486564/pdf/nihms-2024268.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168365924006242?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365924006242?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11486564/

Fields of Study

Nanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryPARP inhibition in cancer therapy

MeSH Terms

Nanoparticle Drug Delivery SystemEndoplasmic Reticulum Chaperone BiPAnimalsAntineoplastic AgentsFemaleHeat-Shock ProteinsHumansMaytansineMice, Inbred C57BLOvarian NeoplasmsCell Line, TumorMiceNanoparticles

Keywords

Ovarian cancerTargeted drug deliveryMedicineDrugTargeted therapyDrug deliveryCancerOncologyCancer researchPharmacologyInternal medicineNanotechnologyMaterials scienceMetastasisWomen's HealthLipid NanoparticleAntitumor Immune Response

Sustainable Development Goals

SDG 0: Good health and well-being